Multiple scerosis. Multiple sclerosis
Conditions
Interventions
Intervention 1: Intervention group:Aspirin,500 mg oral tablet, once daily for 42 days and Amantadine,100-mg oral capsule , once daily for 42 days. Intervention 2: Control group:Amantadine,100-mg oral
Treatment - Drugs
Intervention group:Aspirin,500 mg oral tablet, once daily for 42 days and Amantadine,100-mg oral capsule , once daily for 42 days.
Control group:Amantadine,100-mg oral capsule , once daily for 42 days and oral placebo tablet for 42 days .
Sponsors
Kerman Neuroscience Reserch Center
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Definite diagnosis of multiple sclerosis; age between 20-50 years; disability scour =6 on the extended disability status scale patients; fatigue score =4 on the fatigue severity scale. Exclusion criteria: Patients with current or recent (within 2 months ago) use of medications or allergy to asprin or amantadin.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue Severity Scale. Timepoint: Before intervention,30 days after intervention,42days after intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAkbar Hamzei Moghaddam
Kerman Neuroscience Research Center
Outcome results
None listed